E. Gerald Kay
2022
In 2022, E. Gerald Kay earned a total compensation of $286.4K as Executive Chairman and President at Integrated Biopharma.
Compensation breakdown
Option Awards | $33,651 |
---|---|
Salary | $215,693 |
Other | $37,036 |
Total | $286,380 |
Kay received $215.7K in salary, accounting for 75% of the total pay in 2022.
Kay also received $33.7K in option awards and $37K in other compensation.
Rankings
In 2022, E. Gerald Kay's compensation ranked 5,143rd out of 5,760 executives tracked by ExecPay. In other words, Kay earned more than 10.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,143 out of 5,760 | 11th |
Division Manufacturing | 2,825 out of 3,136 | 10th |
Major group Chemicals And Allied Products | 1,314 out of 1,422 | 8th |
Industry group Drugs | 1,235 out of 1,323 | 7th |
Industry Pharmaceutical Preparations | 902 out of 969 | 7th |
Source: SEC filing on October 27, 2023.
Kay's colleagues
We found four more compensation records of executives who worked with E. Gerald Kay at Integrated Biopharma in 2022.